Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Mesoblast Ltd banner

Mesoblast Ltd
NASDAQ:MESO

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
NASDAQ:MESO
Watchlist
Price: 16.67 USD -1.3%
Market Cap: $1.9B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

MESO Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MESO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MESO is 18.46 USD with a low forecast of 17.96 USD and a high forecast of 19.51 USD.

MESO Lowest Forecast
Wall Street Target
17.96 USD
8% Upside
MESO Average Forecast
Wall Street Target
18.46 USD
11% Upside
MESO Highest Forecast
Wall Street Target
19.51 USD
17% Upside
Lowest
Price Target
17.96 USD
8% Upside
Average
Price Target
18.46 USD
11% Upside
Highest
Price Target
19.51 USD
17% Upside
Mesoblast Ltd Competitors:
Price Targets
WLFC
Willis Lease Finance Corp
-17% Downside
ESQ
Esquire Financial Holdings Inc
13% Upside
FBIZ
First Business Financial Services Inc
18% Upside
AFYA
Afya Ltd
30% Upside
WLFC
Willis Lease Finance Corp
-17% Downside
ESQ
Esquire Financial Holdings Inc
13% Upside
FBIZ
First Business Financial Services Inc
18% Upside
AFYA
Afya Ltd
30% Upside
PTCT
PTC Therapeutics Inc
28% Upside

Revenue
Forecast

-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
-1% / Year
Past Growth
177% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
MESO intrinsic value, competitors valuation, and company profile.
DCF Valuation
MESO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MESO stock valuation using valuation multiples.
Wall Street Estimates
MESO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MESO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MESO's stock price target?
Price Target
18.46 USD

According to Wall Street analysts, the average 1-year price target for MESO is 18.46 USD with a low forecast of 17.96 USD and a high forecast of 19.51 USD.

What is Mesoblast Ltd's Revenue forecast?
Projected CAGR
177%

For the last 14 years the compound annual growth rate for Mesoblast Ltd's revenue is -1%. The projected CAGR for the next 3 years is 177%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.